{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:07:45Z","timestamp":1770818865149,"version":"3.50.1"},"reference-count":30,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2016,3,14]]},"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1136\/ejhpharm-2016-000877","type":"journal-article","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T22:44:32Z","timestamp":1462488272000},"page":"233-238","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Cytoreductive surgery with intraperitoneal chemotherapy in the management of peritoneal surface malignancy: a pharmacist's perspective"],"prefix":"10.1136","volume":"23","author":[{"given":"Priya","family":"Mistry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faheez","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Dayal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom D","family":"Cecil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan J","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2016,4,5]]},"reference":[{"key":"2024052709010628000_23.4.233.1","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/bjc.2013.82","article-title":"Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades","volume":"108","author":"Kerscher","year":"2013","journal-title":"Br J Cancer"},{"key":"2024052709010628000_23.4.233.2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S1055-3207(03)00048-6","article-title":"Peritonectomy procedures","volume":"12","author":"Sugarbaker","year":"2003","journal-title":"Surg Clin North Am"},{"key":"2024052709010628000_23.4.233.3","doi-asserted-by":"publisher","DOI":"10.1007\/DCR.0b013e318202f026"},{"key":"2024052709010628000_23.4.233.4","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.3747\/co.v18i2.663","article-title":"A new standard of care for the management of peritoneal surface malignancy","volume":"18","author":"Mohamed","year":"2011","journal-title":"Curr Oncol"},{"key":"2024052709010628000_23.4.233.5","unstructured":"National Institute for Health and Clinical Excellence (NICE). Complete cytoreduction for pseudomyxoma peritonei (Sugarbaker technique):IPG56. 2004. https:\/\/www.nice.org.uk\/guidance\/ipg56 (accessed 12\/09\/2015)."},{"key":"2024052709010628000_23.4.233.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2006.03.005"},{"key":"2024052709010628000_23.4.233.7","unstructured":"NHS Commissioning Board. Clinical Commissioning Policy: Cytoreductive Surgery for Peritoneal Carcinomatosis:NHSCB\/A8f. 2013. http:\/\/www.england.nhs.uk\/wp-content\/uploads\/2013\/04\/a08-p-a.pdf (accessed 12\/09\/2015)."},{"key":"2024052709010628000_23.4.233.8","first-page":"F433","article-title":"The transport barrier in intraperitoneal therapy","volume":"288","author":"Flessner","year":"2005","journal-title":"Am J Physiol"},{"key":"2024052709010628000_23.4.233.9","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/89.7.480"},{"key":"2024052709010628000_23.4.233.10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4251\/wjgo.v2.i1.19","article-title":"Pharmacological rationale for treatments of peritoneal surface malignancy from colorectal cancer","volume":"2","author":"Sugarbaker","year":"2010","journal-title":"World J Gastrointest Oncol"},{"key":"2024052709010628000_23.4.233.11","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.10-2-112"},{"key":"2024052709010628000_23.4.233.12","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2004.08.014"},{"key":"2024052709010628000_23.4.233.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2013.01.001"},{"key":"2024052709010628000_23.4.233.14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.19.7160"},{"key":"2024052709010628000_23.4.233.15","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/1477-7819-12-332","article-title":"Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis","volume":"12","author":"Marcotte","year":"2014","journal-title":"World J Surg Oncol"},{"key":"2024052709010628000_23.4.233.16","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000133183.15705.71"},{"key":"2024052709010628000_23.4.233.17","unstructured":"Sugarbaker PH . Cytoreductive surgery & perioperative chemotherapy for peritoneal surface malignancy. Chapter 1: an overview of peritonectomy, visceral resections, and perioperative chemotherapy for peritoneal surface malignancy. In: Paul Sugarbaker PH , ed. Textbook and video atlas. North Woodbury, CT: Cine-Med Publishing, Inc., 2013:24\u20136."},{"key":"2024052709010628000_23.4.233.18","doi-asserted-by":"publisher","DOI":"10.1053\/ejso.2002.1397"},{"key":"2024052709010628000_23.4.233.19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3802\/jgo.2015.26.1.54","article-title":"Hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel in advanced ovarian cancer: a multicenter prospective observational study","volume":"26","author":"Coccolini","year":"2015","journal-title":"J Gynecol Oncol"},{"key":"2024052709010628000_23.4.233.20","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s12094-012-0888-x","article-title":"Intraperitoneal bevacizumab combined with cytoreductive surgery: as pre-clinical study of tolerance and pharmacokinetics in an animal model","volume":"14","author":"Passot","year":"2012","journal-title":"Clin Transl Oncol"},{"key":"2024052709010628000_23.4.233.21","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25423"},{"key":"2024052709010628000_23.4.233.22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-148"},{"key":"2024052709010628000_23.4.233.23","doi-asserted-by":"crossref","first-page":"378064","DOI":"10.1155\/2012\/378064","article-title":"Pharmacokinetics of the Perioperative Use of Cancer Chemotherapy in Peritoneal Surface Malignancy Patients","volume":"2012","author":"Van der Speeten","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"2024052709010628000_23.4.233.24","first-page":"1096","article-title":"Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells","volume":"41","author":"Teicher","year":"1981","journal-title":"Cancer Res"},{"key":"2024052709010628000_23.4.233.25","doi-asserted-by":"publisher","DOI":"10.1016\/S1055-3207(03)00039-5"},{"key":"2024052709010628000_23.4.233.26","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-007-9648-5"},{"key":"2024052709010628000_23.4.233.27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijpharm.2014.12.025","article-title":"Stability of oxaliplatin in chloride-containing carrier solutions used in hyperthermic intraperitoneal chemotherapy","volume":"479","author":"Mehta","year":"2015","journal-title":"Int J Pharm"},{"key":"2024052709010628000_23.4.233.28","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v2.i2.68"},{"key":"2024052709010628000_23.4.233.29","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1111\/codi.12444","article-title":"The use of cardiac output monitoring to guide the administration of intravenous fluid during hyperthermic intraperitoneal chemotherapy","volume":"15","author":"Thanigaimani","year":"2013","journal-title":"Colorectal Dis"},{"key":"2024052709010628000_23.4.233.30","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1475-2891-12-118","article-title":"The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in patients with cancer undergoing hyperthermic intraperitoneal chemotherapy","volume":"12","author":"Vashi","year":"2013","journal-title":"Nutr J"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2016-000877","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T16:01:21Z","timestamp":1716825681000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2016-000877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,5]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,6,24]]},"published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1136\/ejhpharm-2016-000877"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2016-000877","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,5]]}}}